Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain

Objective This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy. Methods SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical t...

Descripción completa

Detalles Bibliográficos
Autores: Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e, Paja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9, Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4, González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977ac, Martín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04, Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4, García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55, Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bd, Vicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513, Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77, Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40, Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbe, Picón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29c, Díaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccd, Perdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcd, Manjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0f, Rebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694, Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746, María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004, Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907, Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772, Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4, Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08, Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517, Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21, Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8, Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432, Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50, Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838, Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73, Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70, Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328d, Moya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9ab, Gutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419, Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612, Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23, Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/122073
Acceso en línea:https://hdl.handle.net/10171/122073
Access Level:acceso abierto
Palabra clave:primary aldosteronism
spironolactone
eplerenone
renin
aldosterone
id ES_f7dcd7c1bbae08b1126ccfc68c3d0326
oai_identifier_str oai:dadun.unav.edu:10171/122073
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
title Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
spellingShingle Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e
primary aldosteronism
spironolactone
eplerenone
renin
aldosterone
title_short Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
title_full Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
title_fullStr Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
title_full_unstemmed Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
title_sort Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
dc.creator.none.fl_str_mv Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e
Paja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9
Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4
González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977ac
Martín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04
Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4
García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55
Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bd
Vicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513
Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77
Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40
Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbe
Picón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29c
Díaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccd
Perdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcd
Manjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0f
Rebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694
Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746
María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004
Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907
Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772
Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4
Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08
Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517
Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21
Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8
Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432
Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50
Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838
Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73
Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70
Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328d
Moya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9ab
Gutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419
Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612
Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23
Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5
author Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e
author_facet Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e
Paja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9
Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4
González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977ac
Martín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04
Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4
García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55
Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bd
Vicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513
Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77
Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40
Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbe
Picón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29c
Díaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccd
Perdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcd
Manjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0f
Rebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694
Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746
María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004
Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907
Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772
Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4
Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08
Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517
Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21
Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8
Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432
Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50
Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838
Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73
Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70
Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328d
Moya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9ab
Gutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419
Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612
Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23
Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5
author_role author
author2 Paja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9
Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4
González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977ac
Martín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04
Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4
García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55
Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bd
Vicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513
Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77
Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40
Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbe
Picón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29c
Díaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccd
Perdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcd
Manjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0f
Rebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694
Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746
María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004
Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907
Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772
Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4
Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08
Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517
Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21
Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8
Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432
Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50
Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838
Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73
Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70
Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328d
Moya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9ab
Gutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419
Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612
Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23
Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv primary aldosteronism
spironolactone
eplerenone
renin
aldosterone
topic primary aldosteronism
spironolactone
eplerenone
renin
aldosterone
description Objective This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy. Methods SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical treatment with mineralocorticoid receptor antagonist (MRA) as first-line or postsurgical therapy and about antihypertensive medications used before PA targeted treatment (MRA or adrenalectomy) was included. We reported surgically and medically treated patients at baseline and at last available follow-up and evaluated clinical and biochemical responses according to Primary Aldosteronism Surgical Outcome (PASO) and Primary Aldosteronism Medical treatment Outcome (PAMO) criteria. Results A total of 997 patients with PA were included. Before PA diagnosis, the classes of antihypertensive drugs most used were calcium-channel blockers (66%) and angiotensin II receptor blockers (48.4%). Of the initial cohort, 880 patients had at least 1 visit available after initiation of MRA (N = 511 as first-line therapy, N = 47 postsurgery) or adrenalectomy (N = 322). The median defined daily dose of MRA therapy was 1.33. Spironolactone was more prescribed than eplerenone (58% vs 42%). Eplerenone was better tolerated than spironolactone (AEs in 4% vs 18%), particularly among males. After a median follow-up of 35 and 17 months for medically and surgically managed patients, the latter achieved a complete biochemical (68.1%) or clinical (33.6%) response more frequently than people under MRA as first-line therapy (48.6% and 15.7%; P < .001). Conclusion This study underscores the need to optimize PA medical management in Spain to improve patient clinical and biochemical outcomes, since currently the proportion of patients achieving complete clinical and biochemical response with MRA is quite low.
publishDate 2025
dc.date.none.fl_str_mv 2025
2025-01-01
2025
2025-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/122073
url https://hdl.handle.net/10171/122073
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford Academic
publisher.none.fl_str_mv Oxford Academic
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869424948366278656
spelling Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in SpainGoi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4ePaja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977acMartín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bdVicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbePicón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29cDíaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccdPerdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcdManjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0fRebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328dMoya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9abGutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5primary aldosteronismspironolactoneeplerenonereninaldosteroneObjective This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy. Methods SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical treatment with mineralocorticoid receptor antagonist (MRA) as first-line or postsurgical therapy and about antihypertensive medications used before PA targeted treatment (MRA or adrenalectomy) was included. We reported surgically and medically treated patients at baseline and at last available follow-up and evaluated clinical and biochemical responses according to Primary Aldosteronism Surgical Outcome (PASO) and Primary Aldosteronism Medical treatment Outcome (PAMO) criteria. Results A total of 997 patients with PA were included. Before PA diagnosis, the classes of antihypertensive drugs most used were calcium-channel blockers (66%) and angiotensin II receptor blockers (48.4%). Of the initial cohort, 880 patients had at least 1 visit available after initiation of MRA (N = 511 as first-line therapy, N = 47 postsurgery) or adrenalectomy (N = 322). The median defined daily dose of MRA therapy was 1.33. Spironolactone was more prescribed than eplerenone (58% vs 42%). Eplerenone was better tolerated than spironolactone (AEs in 4% vs 18%), particularly among males. After a median follow-up of 35 and 17 months for medically and surgically managed patients, the latter achieved a complete biochemical (68.1%) or clinical (33.6%) response more frequently than people under MRA as first-line therapy (48.6% and 15.7%; P < .001). Conclusion This study underscores the need to optimize PA medical management in Spain to improve patient clinical and biochemical outcomes, since currently the proportion of patients achieving complete clinical and biochemical response with MRA is quite low.Oxford AcademicDadun. Depósito Académico Digital Universidad de Navarra20252025-01-0120252025-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/122073reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/1220732026-06-21T12:47:57Z
score 15,81155